Dr. Jortani is a Professor of Pathology and Laboratory Medicine at the University of Louisville School of Medicine.  He is a board-certified clinical chemist and a practicing toxicologist.  He is an Associate Director of the University of Louisville’s Clinical Chemistry and Toxicology Laboratory.  He has served as a representative of several national organizations in the area of laboratory medicine such as the American Association for Clinical Chemistry (AACC), American Board for Clinical Chemistry (ABCC) and the Commission on Accreditation in Clinical Chemistry (ComACC). 



Dr. Jortani is a co-founder and the past chair of the Clinical Proteomics Division of the AACC.  He is on the editorial boards of Clinica
Chemica Acta and Clinical Proteomics, Therapeutic Drug Monitoring.  His research interests are proteomics, detection and measurement of drugs, therapeutics and poisons, and the use of pharmacogenetics in pain management and for postmortem investigations.  Working with other executive officers of the proteomics division and the National Cancer Institute, Dr. Jortani has been instrumental in establishing a memorandum of understanding (MOU) between AACC and the NCI. As the founder of KCTL, Dr. Jortani has served the diagnostic industry for over 20 years.  He has secured several million dollars of funding for clinical research.  He has been a co-inventor on at least 5 patent applications, all of which are various stages of discovery proceeding toward translation and novel diagnostics.



Dr. Jortani is also one of the leaders in the field of pharmacogenetics specifically focusing on personalized pain management and PGx-guided forensic toxicology investigations and pain management.  As a liaison representing the AACC to the College of American Pathologists, he co-founded the first proficiency testing materials in the area of clinical pharmacogenetics.  His efforts by participating in the writing of the Laboratory Medicine Practice Guidelines in Pharmacogenetics and his directing of clinical trials in this area will contribute to substantial advancement in this area.
 



Additional Websites associated with Dr. Jortani:
University of Louisville School of Medicine, Department of Pathology & Laboratory






Contact Us:

​​Saeed A. Jortani Ph.D., DABCC

 Publication Examples



Long interspersed nuclear element-1 mobilization as a target in cancer diagnostics, prognostics, and therapeutics 

Lavasanifar, Afsaneh & N. Sharp, Cierra & Korte, Erik & Yin, Tyler & Hossainijad, Keivan & A. Jortani, Saeed.

Feb 2019





Discovery of the Long Interspersed Nuclear Element-1 activation product [Open Reading Frame-1 (ORF1) protein] in human blood

Hossainijad, Keivan & Yin, Tyler & T. Gaskins, Jeremy & L. Bailan, James & A. Jortani, Saeed. 

Oct 2018





Lack of Influence by CYP3A4 and CYP3A5 Genotypes on Pain Relief by Hydrocodone in Postoperative Cesarean Section Pain Management 

Hossainijad, Keivan & Yin, Tyler, & T. Gaskins, Jeremy, & Elaine Stauble, M & Wu, Yanhong & Jannetto, Paul & L. Langman, Loralie & A. Jortani, Saeed.

Sep 2018





Analytical interference of HBOC-201 (Homopure, a synthetic hemoglobin-based oxygen carrier) on four common clinical chemistry platforms 

Korte, Erik & Pozzi, Nicole & Wardrip, Nina & Tayyeb Ayyoubi, M & A. Jortani, Saeed. 

July 2018






Multicenter evaluation of analytical characteristics of the Elecsys Periostin immunoassay 

Palme, Stefan & H. Christenson, Robert A. Jortani, Saeed & E. Ostlund, Richard & Kolm, Ruediger & Kopal, Guido & P. Laubender, Ruediger. 

Feb 2017